Related Experiment Video
Updated: Jan 22, 2026

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
Published on: February 25, 2016
Sp1 contributes to radioresistance of cervical cancer through targeting G2/M cell cycle checkpoint CDK1
Yuan-Run Deng1, Xiao-Jing Chen2, Wei Chen1
1Department of Obstetrics and Gynecology, The Third Affiliated Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
Background/Aims:
Radioresistance remains a significant obstacle in the therapy of cervical cancer, and the mechanism of it is still unclear. We aimed to investigate the role of specificity protein 1 (Sp1) in radioresistance of cervical cancer.
Methods:
Sp1 was examined immunohistochemically on tissues from 36 human cervical cancer patients. We used RT-qPCR and Western blot to examine the expression of Sp1 in irradiated cervical cancer cell lines SiHa and HeLa. The role of Sp1 in radioresistance of cervical cancer cells was assessed by colony-formation assay and cell cycle analysis. Dual-luciferase reporter assay was performed to detect the downstream of Sp1.
Results:
High Sp1 expression was positively correlated with advanced International Federation of Gynecology and Obstetrics (FIGO) stage, lymph node metastasis, and lymphovascular space invasion (LVSI) of cervical cancer. The expression of Sp1 was dose-dependently increased in irradiated cervical cancer cell lines at both mRNA and protein levels. Colony-formation assay showed that alteration of Sp1 expression affected the survival of cervical cancer cells with radiotherapy (RT) treatment. Knockdown of Sp1 significantly strengthened the cellular response to radiation by inducing G2/M arrest in cervical cancer cells. Overexpression of Sp1 significantly decreased G2/M arrest in cervical cancer cells, which was related to upregulation of CDK1 expression. Dual-luciferase reporter assay showed the direct effect of Sp1 on the transcriptional activation of CDK1.
Conclusion:
Sp1 may contribute to radioresistance through inhibiting G2/M phase arrest by targeting CDK1, and be considered as a potential therapeutic target to promote the effect of RT for patients with cervical cancer.
Insights
Specificity protein 1 (Sp1) promotes cervical cancer radioresistance by inhibiting G2/M arrest via CDK1. Targeting Sp1 could enhance radiotherapy effectiveness in cervical cancer patients.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Radioresistance is a major challenge in cervical cancer treatment.
- The underlying mechanisms of radioresistance in cervical cancer are not fully understood.
- Specificity protein 1 (Sp1) is investigated for its potential role in cervical cancer radioresistance.
Purpose of the Study:
- To investigate the role of Sp1 in the radioresistance of cervical cancer.
- To determine the correlation between Sp1 expression and clinical parameters in cervical cancer.
- To elucidate the molecular mechanism by which Sp1 influences cervical cancer cell response to radiotherapy.
Main Methods:
- Immunohistochemistry was used to assess Sp1 expression in 36 human cervical cancer tissues.
- RT-qPCR and Western blot analyzed Sp1 expression in irradiated SiHa and HeLa cell lines.
- Colony-formation assays, cell cycle analysis, and dual-luciferase reporter assays were employed to evaluate Sp1 function and its downstream targets.
Main Results:
- High Sp1 expression correlated with advanced FIGO stage, lymph node metastasis, and lymphovascular space invasion (LVSI).
- Sp1 expression increased dose-dependently in irradiated cervical cancer cells at both mRNA and protein levels.
- Sp1 knockdown enhanced radiosensitivity by inducing G2/M arrest, while Sp1 overexpression reduced it, linked to CDK1 upregulation.
Conclusions:
- Sp1 contributes to cervical cancer radioresistance by inhibiting G2/M phase arrest through targeting CDK1.
- Sp1 represents a potential therapeutic target to improve radiotherapy outcomes in cervical cancer.
- Targeting Sp1 may offer a strategy to overcome radioresistance and enhance treatment efficacy.
Related Concept Videos
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
Targeted Cancer Therapies
There are several types of targeted therapies against...
What is the Cell Cycle?
What is the Cell Cycle?
The Sulfur Cycle
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...

